Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 2
2018 2
2019 4
2020 4
2021 3
2022 3
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Oral Cholera Vaccine Efficacy and Effectiveness.
Song KR, Lim JK, Park SE, Saluja T, Cho SI, Wartel TA, Lynch J. Song KR, et al. Among authors: saluja t. Vaccines (Basel). 2021 Dec 15;9(12):1482. doi: 10.3390/vaccines9121482. Vaccines (Basel). 2021. PMID: 34960228 Free PMC article. Review.
The Dengue virus in Nepal: gaps in diagnosis and surveillance.
Gupta BP, Haselbeck A, Kim JH, Marks F, Saluja T. Gupta BP, et al. Among authors: saluja t. Ann Clin Microbiol Antimicrob. 2018 Jul 16;17(1):32. doi: 10.1186/s12941-018-0284-7. Ann Clin Microbiol Antimicrob. 2018. PMID: 30008269 Free PMC article. Review.
Review on the Recent Advances on Typhoid Vaccine Development and Challenges Ahead.
Syed KA, Saluja T, Cho H, Hsiao A, Shaikh H, Wartel TA, Mogasale V, Lynch J, Kim JH, Excler JL, Sahastrabuddhe S. Syed KA, et al. Among authors: saluja t. Clin Infect Dis. 2020 Jul 29;71(Suppl 2):S141-S150. doi: 10.1093/cid/ciaa504. Clin Infect Dis. 2020. PMID: 32725225 Free PMC article. Review.
A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjugate vaccine in healthy volunteers in eastern Nepal.
Chaudhary S, Shah GS, Bhatta NK, Poudel P, Rai B, Uranw S, Tripathi PM, Khanal B, Ghimire A, Rai N, Gupta BP, Vemula S, Wartel TA, Sahastrabuddhe S, Saluja T. Chaudhary S, et al. Among authors: saluja t. Hum Vaccin Immunother. 2023 Dec 31;19(1):2203634. doi: 10.1080/21645515.2023.2203634. Hum Vaccin Immunother. 2023. PMID: 37128723 Free PMC article. Clinical Trial.
Conducting a phase III clinical trial in children during the COVID- 19 pandemic: Experience and lessons learnt from a clinical research facility of Nepal.
Chapagain RH, Maharjan J, Adhikari S, Thapa P, Kunwar K, Giri BR, Shrestha NJ, Shrestha AK, Shrestha SK, Tamang SM, Cho H, Park EL, Lee J, Lee J, Kim DR, Yang JS, Saluja T, Wartel A, Lynch J, Song KR. Chapagain RH, et al. Among authors: saluja t. Hum Vaccin Immunother. 2023 Aug 1;19(2):2239680. doi: 10.1080/21645515.2023.2239680. Hum Vaccin Immunother. 2023. PMID: 37539816 Free PMC article. Review.
Safety and immunogenicity of conjugate vaccine for typhoid (Vi-DT): Finding from an observer-blind, active-controlled, randomized, non-inferiority, phase III clinical trial among healthy volunteers.
Tamrakar D, Poudel P, Thapa P, Singh S, Khadgi A, Thapa S, Tamrakar R, Shrestha A, Madhup S, Rai GK, Gupta BP, Saluja T, Sahastrabuddhe S, Shrestha R. Tamrakar D, et al. Among authors: saluja t. Hum Vaccin Immunother. 2024 Dec 31;20(1):2301631. doi: 10.1080/21645515.2023.2301631. Epub 2024 Jan 8. Hum Vaccin Immunother. 2024. PMID: 38189360 Free PMC article. Clinical Trial.
Factors affecting willingness to participate in vaccine clinical trials in an underdeveloped country: perspective from Nepal.
Chapagain RH, Adhikari S, Giri BR, Ray P, Shrestha NJ, Prajapati B, Joshi P, Pokharel S, Tamang SM, Gupta BP, Wartel TA, Sahastrabuddhe S, Rai GK, Saluja T. Chapagain RH, et al. Among authors: saluja t. Hum Vaccin Immunother. 2022 Nov 30;18(5):2051413. doi: 10.1080/21645515.2022.2051413. Epub 2022 Mar 30. Hum Vaccin Immunother. 2022. PMID: 35353657 Free PMC article.
Immune non-interference and safety study of Vi-DT typhoid conjugate vaccine with a measles, mumps and rubella containing vaccine in 9-15 months old Nepalese infants.
Saluja T, Rai GK, Chaudhary S, Kanodia P, Giri BR, Kim DR, Yang JS, Park IY, Kyung SE, Vemula S, Reddy E J, Kim B, Gupta BP, Jo SK, Ryu JH, Park HK, Shin JH, Lee Y, Kim H, Kim JH, Mojares ZR, Wartel TA, Sahastrabuddhe S. Saluja T, et al. Vaccine. 2022 Sep 22;40(40):5828-5834. doi: 10.1016/j.vaccine.2022.08.034. Epub 2022 Sep 3. Vaccine. 2022. PMID: 36064672 Clinical Trial.
19 results